Read about Twist Biopharma's development of antibody candidates against GPCR therapeutic targets ADORA2A and GLP1R
Here is a description of your company. Proin ex id consectetur lobortis. Aliquam, velit vel faucibus dapibus, augue justo ullamcorper turpis, nec convallis metus nunc vel turpis.
